| Patents for A61P 3 - Drugs for disorders of the metabolism (129,789) |
|---|
| 09/23/2004 | CA2518194A1 6-substituted nicotinamide derivatives as opioid receptor antagonists |
| 09/23/2004 | CA2517569A1 Indole derivatives useful for the treatment of diseases |
| 09/22/2004 | EP1460074A1 Substituted amino alkyl compounds |
| 09/22/2004 | EP1460073A1 Substituted piperidine and piperazine derivatives as melanocortin-4 receptor modulators |
| 09/22/2004 | EP1460070A1 Substituted piperidine and piperazine derivatives as melanocortin-4 receptor modulators |
| 09/22/2004 | EP1460069A1 Substituted cyclohexyl and piperidinyl derivatives as melanocortin-4 receptor modulators |
| 09/22/2004 | EP1460064A1 Indole-2-carboxamide derivatives useful as beta-2 agonists |
| 09/22/2004 | EP1459767A1 Hard capsules |
| 09/22/2004 | EP1459755A1 Body weight gain inhibitor |
| 09/22/2004 | EP1458883A2 Screening method for agents useful in treating diabetes |
| 09/22/2004 | EP1458865A2 Human vanilloid receptor protein and polynucleotide sequence encoding same |
| 09/22/2004 | EP1458758A2 Adiponectin fragments and conjugates |
| 09/22/2004 | EP1458754A2 Novel death associated proteins of the thap family and related par4 pathways involved in apoptosis control |
| 09/22/2004 | EP1458746A2 Cyclic tetrapeptide compound and use thereof |
| 09/22/2004 | EP1458741A2 Rna interference mediated inhibition of gene expression using chemically modified short interfering nucleic acid |
| 09/22/2004 | EP1458723A1 Fused heterocyclic succinimidecompounds and analogs thereof, modulators of nuclear hormone receptor function |
| 09/22/2004 | EP1458722A1 Pyrrolopyrimidines as phosphodiesterase vii inhibitors |
| 09/22/2004 | EP1458721A1 3-heteroaryl-3,5-dihydro-4-oxo-4h-pyridazino 4,5-b]indole-1-carboxamide derivatives, their preparation and therapeutic use |
| 09/22/2004 | EP1458718A1 Quinolinones as prostaglandin receptor ligands |
| 09/22/2004 | EP1458717A1 Aroyl pyridinones |
| 09/22/2004 | EP1458714A1 3,4-dihydro-1h-isoquinoloin-2-yl-derivatives |
| 09/22/2004 | EP1458712A2 Novel compounds |
| 09/22/2004 | EP1458710A1 Heteroaryl substituted pyrrole modulators of metabotropic glutamate receptor-5 |
| 09/22/2004 | EP1458708A2 Heteroaryl substituted triazole modulators of metabotropic glutamate receptor-5 |
| 09/22/2004 | EP1458694A2 Therapeutic compounds for treating dyslipidemic conditions |
| 09/22/2004 | EP1458690A1 5,6-diaryl-pyrazine-2-amide derivatives as cb1 antagonists |
| 09/22/2004 | EP1458688A1 Quinazolinone derivative |
| 09/22/2004 | EP1458687A2 Pyrimidine compounds |
| 09/22/2004 | EP1458683A1 Heteroaryl-substituted aminocyclohexane derivatives |
| 09/22/2004 | EP1458680A1 Prodrugs to d-prolines |
| 09/22/2004 | EP1458677A1 3-phenyl-2-arylalkylthiopropionic acid derivatives as selective agonists of ppar-alpha |
| 09/22/2004 | EP1458676A2 Compounds for the treatment of inflammatory disorders |
| 09/22/2004 | EP1458673A1 Substituted phenylpropionic acid derivatives as agonists to human peroxisome proliferator-activated receptor alpha (ppar) |
| 09/22/2004 | EP1458672A1 Substituted phenylpropionic acid derivatives as agonists to human peroxisome proliferator-activated receptor alpha(ppar) |
| 09/22/2004 | EP1458412A1 Pharmaceutical composition comprising an alpha-glucosidase inhibitor and a 4-oxobutanoic acid, and the use thereof for treating diabetes |
| 09/22/2004 | EP1458411A2 Anti-rank ligand monoclonal antibodies useful in treatment of rank ligand mediated disorders |
| 09/22/2004 | EP1458400A1 Liquid bisphosphonate formulations for bone disorders |
| 09/22/2004 | EP1458399A1 Pregnane steroids for use in the treatment of cns disorders |
| 09/22/2004 | EP1458392A2 Acridone inhibitors of impdh enzyme |
| 09/22/2004 | EP1458386A1 Aroyl pyrrole heteroeryl and methanols useful for treating a central nervous system disorder |
| 09/22/2004 | EP1458385A2 Heteroaryl substituted imidazole modulators of metabotropic glutamate receptor-5 |
| 09/22/2004 | EP1458383A2 Heteroaryl substituted pyrazole modulators of metabotropic glutamate receptor-5 |
| 09/22/2004 | EP1458382A1 Amide derivatives as gk activators |
| 09/22/2004 | EP1458375A2 Compositions for decreasing activity of hormone-sensitive lipase |
| 09/22/2004 | EP1458374A2 Compounds and uses thereof for decreasing activity of hormone-sensitive lipase |
| 09/22/2004 | EP1458364A1 Pharmaceutical compositions comprising metformine and glibenclamide for the treatment of type-ii diabetes mellitus |
| 09/22/2004 | EP1458353A1 Formulation dosage form for the controlled delivery of ther apeutic agents |
| 09/22/2004 | EP1458352A1 Solid dose micro implant |
| 09/22/2004 | EP1458337A1 Stable surfactant compositions for suspending components |
| 09/22/2004 | EP1458240A2 Nucleic acid constructs useful for glucose regulated production of human insulin in somatic cell lines |
| 09/22/2004 | EP1280788B1 Method for the production of l-ascorbic acid by lactonisation of 2-keto-l-gulonic acid or 2-keto-l-gulonate esters |
| 09/22/2004 | EP1274709B1 Salts of bicyclic, n-acylated imidazo-3-amines and imidazo-5-amines |
| 09/22/2004 | EP1235835A4 Chromium-histidine complexes as nutrient supplements |
| 09/22/2004 | EP1222187B1 Heterocyclic compounds useful as inhibitors of tyrosine kinases |
| 09/22/2004 | EP1200438B1 Method for making debromohymenialdisine and analogs thereof |
| 09/22/2004 | EP1192165B1 Substituted heterocycle fused gamma-carbolines |
| 09/22/2004 | EP1189904B1 Substituted heterocycle fused gamma-carbolines |
| 09/22/2004 | EP1144402B1 Substituted oximes and hydrazones as neurokinin antagonists |
| 09/22/2004 | EP1140981B1 Tripeptide compounds useful as selective inhibitors of aminopeptidase a and corresponding pharmaceutical compositions |
| 09/22/2004 | EP1124801B1 Piperidine and pyrrolidine derivatives comprising a nitric oxide donor for treating stress |
| 09/22/2004 | EP1100503B1 Non-imidazole alkylamines as histamine h 3?-receptor ligands and their therapeutic applications |
| 09/22/2004 | EP1054869B1 3,4-dihydroquinoline derivatives as nitrogen monoxide synthase (nos) inhibitors |
| 09/22/2004 | EP1007691B1 Methods and compositions for synthesis of long chain polyunsaturated fatty acids |
| 09/22/2004 | EP0914119B1 Process for forming solid oral dosage forms of valsartan |
| 09/22/2004 | EP0623133B1 Substituted amino alkyl compounds |
| 09/22/2004 | CN1531600A New polynucleotides and polypeptides of IFN 2-21 gene |
| 09/22/2004 | CN1531550A Heterocarpine, human GHRH-binding protein |
| 09/22/2004 | CN1531546A Peptide compounds |
| 09/22/2004 | CN1531531A Novel arylsusfonamide compounds for treatment of obesity, type II diabetes and CNS-disorders |
| 09/22/2004 | CN1531529A 4-(benzylidenje-amino)-3-(methylsulfanyl)-4H-(1,2,4) triazin-5-one derivatives having PDE-IV inhibiting and TNF-antagonistic effect for treatment of cardiac diseases and allergies |
| 09/22/2004 | CN1531527A Carbazole derivatives and their use as neuropeptide Y5 receptor ligands |
| 09/22/2004 | CN1531441A Pharmaceutical compositinos which inhibit vascular proliferation and method of use thereof |
| 09/22/2004 | CN1531437A Use of non-digestible polymeric foams to sequester ingested materials thereby inhibiting their absorption by body |
| 09/22/2004 | CN1531433A Synergistic pharmaceutical combination for prevention or treatment of diabetes |
| 09/22/2004 | CN1531429A Medicament, containing effector of glutathione metabolism together with alpha-lipoic acid for use in kidney replacement therapy |
| 09/22/2004 | CN1531425A Urea derivatives as integrin alpha 4 antagonists |
| 09/22/2004 | CN1531398A Animal feed supplement containing D-pantothenic acid and/or its salts, improved method for production thereof, and its use |
| 09/22/2004 | CN1530444A Gene related to blood sugar regulation, protein product and use thereof |
| 09/22/2004 | CN1530372A Inhibitor of hecterocyclic oxoaminoethylol aminosulfonic amine reverse transcripted virus protenase |
| 09/22/2004 | CN1530137A Health food for diabetes patients |
| 09/22/2004 | CN1530119A Composition containing shelled buckwheat kernel extractive and use thereof |
| 09/22/2004 | CN1530107A Insulin resistance treatment by growth hormone secretory hormone |
| 09/22/2004 | CN1530106A Medicine composition for treating diabet mellitus |
| 09/22/2004 | CN1530105A Medicine composition for treating diabets and mellitus |
| 09/22/2004 | CN1530101A Healthy food composition for purifying blood, improving immunity and regulating blood fat |
| 09/22/2004 | CN1530100A Food containing Angelica sinensis extractive and medicine composition thereof |
| 09/22/2004 | CN1167793C Polypeptides encoded by human lipase-like gene, compositions and methods |
| 09/22/2004 | CN1167707C 2,3-O-isopropylidene derivatives of monosaccharides as cell adhesive inhibitors |
| 09/22/2004 | CN1167702C Polymroph of 5-[4-[2-(n-methyl-n-(2-pyridyl)amino)ethoxy]benzyl] thiazolidine-2,4-dione, maleic acid salt |
| 09/22/2004 | CN1167692C Aminothiazole derivatives and their use as CRF receptor ligands |
| 09/22/2004 | CN1167691C Substituted eenzylthiazolidie-2,4-dione derivatives |
| 09/22/2004 | CN1167681C Condensed indoline derivatives and their use as 5HT, in particular 5HT2 receptor ligands |
| 09/22/2004 | CN1167678C 新颖的维生素d类似物 Novel analogues of vitamin d |
| 09/22/2004 | CN1167459C Nutritive healthy food with functions of reducing blood fat and delaying senility and its preparation |
| 09/22/2004 | CN1167432C Hypoglycemic life-elongating tablets and their preparation |
| 09/22/2004 | CN1167426C Preparation of zymolite of blue scad to improve function of brain cells |
| 09/22/2004 | CN1167422C Quinazoline derivatives as angiogenesis inhibitors |
| 09/22/2004 | CN1167414C Preparation of pellet containing fat soluble substances |
| 09/22/2004 | CN1167362C Preparation of slimming health beverage |
| 09/21/2004 | US6794544 Method for the preparation of tetrahydrobenzothiepines |